An anionic residue at position 564 is important for maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor.
暂无分享,去创建一个
[1] J. Baldwin,et al. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.
[2] A. Shenker,et al. A model of the lutropin/choriogonadotropin receptor: insights into the structural and functional effects of constitutively activating mutations. , 1997, Protein engineering.
[3] A. Scheer,et al. The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Perez,et al. Synergism of constitutive activity in alpha 1-adrenergic receptor activation. , 1997, Biochemistry.
[5] A. Shenker,et al. The Role of Asp578 in Maintaining the Inactive Conformation of the Human Lutropin/Choriogonadotropin Receptor* , 1996, The Journal of Biological Chemistry.
[6] T. Sakmar,et al. Functional Interaction of Transmembrane Helices 3 and 6 in Rhodopsin , 1996, The Journal of Biological Chemistry.
[7] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.
[8] H. Khorana,et al. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.
[9] B. Kobilka,et al. Transmembrane Regions V and VI of the Human Luteinizing Hormone Receptor Are Required for Constitutive Activation by a Mutation in the Third Intracellular Loop* , 1996, The Journal of Biological Chemistry.
[10] A. Parfitt,et al. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. , 1996, The New England journal of medicine.
[11] Martin Tj. Actions of Parathyroid Hormone–Related Peptide and Its Receptors , 1996 .
[12] R. Gilchrist,et al. The Luteinizing Hormone/Chorionic Gonadotropin Receptor Has Distinct Transmembrane Conductors for cAMP and Inositol Phosphate Signals* , 1996, The Journal of Biological Chemistry.
[13] J. Spudich,et al. Shuttling between two protein conformations: the common mechanism for sensory transduction and ion transport. , 1996, Current opinion in cell biology.
[14] R. Kraaij. Expression and Activation of Gonadotropin Receptors , 1996 .
[15] J. Konopka,et al. Mutation of Pro-258 in transmembrane domain 6 constitutively activates the G protein-coupled alpha-factor receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[16] H. Brunner,et al. Luteinizing hormone receptor mutations and sex differentiation. , 1996, European journal of endocrinology.
[17] J. Stankova,et al. Mutations of Two Adjacent Amino Acids Generate Inactive and Constitutively Active Forms of the Human Platelet-activating Factor Receptor (*) , 1996, The Journal of Biological Chemistry.
[18] E. Nieschlag,et al. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. , 1996, The Journal of clinical endocrinology and metabolism.
[19] J. Wess,et al. Molecular Mechanisms Involved in Muscarinic Acetylcholine Receptor-mediated G Protein Activation Studied by Insertion Mutagenesis (*) , 1996, The Journal of Biological Chemistry.
[20] B. Bormann,et al. Strong hydrogen bonding interactions involving a buried glutamic acid in the transmembrane sequence of the neu/erbB-2 receptor , 1996, Nature Structural Biology.
[21] S. Swillens,et al. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. , 1996, The Journal of clinical endocrinology and metabolism.
[22] M. Brann,et al. Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis. , 1995, The Journal of pharmacology and experimental therapeutics.
[23] H. Brunner,et al. A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty. , 1995, The Journal of clinical endocrinology and metabolism.
[24] H Weinstein,et al. Related Contribution of Specific Helix 2 and 7 Residues to Conformational Activation of the Serotonin 5-HT2A Receptor (*) , 1995, The Journal of Biological Chemistry.
[25] W. Sadee,et al. Activating and Inactivating Mutations in N- and C-terminal i3 Loop Junctions of Muscarinic Acetylcholine Hm1 Receptors (*) , 1995, The Journal of Biological Chemistry.
[26] L. Blomberg,et al. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] G. K. Ackers,et al. Long-range, small magnitude nonadditivity of mutational effects in proteins. , 1995, Biochemistry.
[28] K. Fahmy,et al. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. , 1994, The Journal of biological chemistry.
[29] T. Minegishi,et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty , 1993, Nature.
[30] J. Parma,et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.
[31] A. Shenker,et al. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation. , 1993, Molecular endocrinology.
[32] R. Lefkowitz,et al. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.
[33] D. Oprian,et al. Constitutive activation of opsin: influence of charge at position 134 and size at position 296. , 1993, Biochemistry.
[34] M. Ascoli,et al. The lutropin/choriogonadotropin receptor ... 4 years later. , 1993, Endocrine reviews.
[35] David J Weber,et al. Quantitative interpretations of double mutations of enzymes. , 1992, Archives of biochemistry and biophysics.
[36] T. Gudermann,et al. Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells. , 1992, The Journal of biological chemistry.
[37] M. Caron,et al. Site-directed mutagenesis of the cytoplasmic domains of the human beta 2-adrenergic receptor. Localization of regions involved in G protein-receptor coupling. , 1988, The Journal of biological chemistry.
[38] D Rodbard,et al. Ligand: a versatile computerized approach for characterization of ligand-binding systems. , 1980, Analytical biochemistry.
[39] M. Ascoli,et al. Mutation of a highly conserved acidic residue present in the second intracellular loop of G-protein-coupled receptors does not impair hormone binding or signal transduction of the luteinizing hormone/chorionic gonadotropin receptor. , 1993, Molecular endocrinology.
[40] W. C. Probst,et al. Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.